Research funder · United States
BrightFocus Foundation
Non-profit organization in the USA
- Grants since 2016
- 717
- Awarded, last 5 years (where amounts are published)
- $108M
- Funded works, last 5 years
- 1 862
- Funded works, all time
- 3 290
Grants
2026–2028 · research · National Glaucoma Research: Standard
Mapping the innate immune landscape of the human optic nerve head in glaucoma
Monica Vetter · University of Utah
2026–2028 · research · National Glaucoma Research: Standard
Smart Insole–Based Foot Clearance Assessment and Biofeedback Intervention to Reduce Foot Trajectory Variability and Fall Risk in Glaucoma Patients
Navid Amini · California State University Los Angeles
2026–2029 · research · Alzheimer's Disease Research: Standard
Decoding Axonal, Synaptic, and Myelination Pathology in Alzheimer's Disease Using a Human Modular Microphysiological Platform
Selene Lomoio · Icahn School of Medicine at Mount Sinai
2026–2028 · research · Alzheimer's Disease Research: Standard
A Neural Plasticity Model of Alzheimer's Dementia in Human Brain Organoids
Matthias Hebisch · Massachusetts General Hospital
2026–2028 · research · Macular Degeneration Research: Standard
Sterically hindered phenol, PMC as a potential novel therapeutic for age-related macular degeneration associated pathologies
Suman Chaudhary · Massachusetts Eye and Ear Infirmary
2026–2029 · research · Alzheimer's Disease Research: Standard
Visual System Vulnerability In Dementia: From Detection To Determinants
Keir Yong · University College London
2026–2027 · research · BrightFocus Foundation: Other
Understanding Natural Protection Against Cognitive Decline: The 100-plus Study
Henne Holstege · Alzheimer Center Of The Vu University Medical Center
2026–2028 · research · National Glaucoma Research: Standard
Machine Learning-Derived Endophenotypes to Uncover Genetic Drivers of Glaucoma Progression
Nazlee Zebardast · Massachusetts Eye and Ear Infirmary
2026–2028 · research · Alzheimer's Disease Research: Standard
Systematic investigation of the impact of Alzheimer’s disease risk genes on microglial activation
Amanda Mcquade · University of California, San Francisco
2026–2029 · research · Alzheimer's Disease Research: Standard
Unraveling pathways to cerebral small vessel disease in VCID and AD with Ferumoxytol-enhanced MRI
Leonardo Rivera-Rivera · University of Wisconsin–Madison
2026–2028 · research · Macular Degeneration Research: Standard
Enabling Targeted Protein Degradation of Extracellular Targets to treat Neovascular Age-related Macular Degeneration
Celia Bisbach · University of Wisconsin–Madison
2026–2029 · research · Alzheimer's Disease Research: Standard
Uncovering mechanisms of myelin-axon pathology in Alzheimer’s disease
Yifei Cai · Shanghai Jiao Tong University
2026–2028 · research · Alzheimer's Disease Research: Standard
Nose-to-Brain Delivery of CD33 siRNA for Treating Alzheimer's Disease
Dominika Pilat · Massachusetts General Hospital
2026–2029 · research · Macular Degeneration Research: Standard
RPE Lipid Degradation and Secretion in Age-Related Macular Degeneration
Jason Miller · University of Michigan
2026–2028 · research · National Glaucoma Research: Standard
Targeting glial-mediated neuroinflammation to prevent axonal degeneration in glaucoma
Cátia Gomes · Indiana University School of Medicine
2026–2028 · research · Macular Degeneration Research: Standard
Impact of sleep deficiency on choroidal neovascularization in a mouse model of AMD
Anaïs Françon · Hôpital Maisonneuve-Rosemont
2026–2027 · research · BrightFocus Foundation: Standard
APP-mediated mechanical signaling and its regulation by Alzheimer’s risk genes
Ben Goult · University of Liverpool
2026–2028 · research · Alzheimer's Disease Research: Standard
PREDICT-PI: Mechanistic Pathways and Predictive Validity of Path Integration in Alzheimer's Disease
Vladislava Segen · German Center for Neurodegenerative Diseases
2026–2028 · research · National Glaucoma Research: Standard
Multiphoton-excited Aqueous Flowmetry: In Vivo Quantification of Conventional Outflow Dynamics
Tyson Kim · University of California, San Francisco
2026–2028 · research · Alzheimer's Disease Research: Standard
Investigating organelle-specific lipid metabolic defects in Alzheimer's disease
Hugo Fernandes · University of Oxford
2026–2028 · research · Alzheimer's Disease Research: Standard
Defining the Role of Astrocytic NLRX1 in Alzheimer's Disease Pathogenesis
Martin Hsu · University of North Carolina at Chapel Hill
2026–2028 · research · Alzheimer's Disease Research: Standard
Human Anterior Hypothalamic Nuclei as a Model of Selective Vulnerability: A Transformative Neuropathology to AD and Circadian Dysfunction
Gowoon Son · Mayo Clinic in Florida
2026–2029 · research · Macular Degeneration Research: Standard
In-Vivo Morpho-Chemical Profiling of AMD Deposits with Combined OCT-Raman Spectroscopy
David Veysset · Massachusetts General Hospital
2026–2029 · research · Macular Degeneration Research: Standard
Human Retina-on-a-Chip: A Next-Generation Model for AMD with Integrated Retinal Organoids and Perfusable Outer Blood–Retina Barrier
Amir Vahabikashi · Northeastern University
2026–2028 · research · Macular Degeneration Research: Standard
Development of new pro-drugs for the treatment of dry age-related macular degeneration through targeted inhibition of cyclooxygenases
Marco Bassetto · University of California, Irvine
2026–2029 · research · Alzheimer's Disease Research: Standard
The impact of social inequality and lifestyle on plasma ATN biomarkers in AD and FTD in Latin America
Claudia Duran-Aniotz · Adolfo Ibáñez University
2025–2027 · research · Alzheimer's Disease Research: Standard
Cerebrovascular pathologies in Down syndrome using 7T postmortem MRI
Jr-Jiun Liou · University of Pittsburgh
2025–2027 · research · National Glaucoma Research: Standard
Characterization of mitochondria and transmitophagy in RGC dendritic arbors
Rob Nickells · University of Wisconsin–Madison
2025–2028 · research · Alzheimer's Disease Research: Standard
Novel genetic and neuroimaging biomarkers of neurodegeneration for the Latin American population.
Carolina Ochoa-Rosales · Adolfo Ibáñez University
2025–2028 · research · Alzheimer's Disease Research: Standard
Unraveling Vascular Pathways in Dementia through Integrated Computational Fluid Dynamics
Daniel Bos · Erasmus MC
2025–2028 · research · Alzheimer's Disease Research: Standard
Multimodal charting of neuroinflammation in Alzheimer's Disease
Feng Tian · Beth Israel Deaconess Medical Center
2025–2027 · research · Macular Degeneration Research: Standard
Biomarker analyses of lifestyle changes for age-related macular degeneration
Joëlle Vergroesen · Erasmus University Medical Center Rotterdam (erasmus Mc)
2025–2028 · research · Alzheimer's Disease Research: Standard
Modulation of choroid plexus renin-angiotensin system in Alzheimer’s disease
Monica Santisteban · Vanderbilt University Medical Center
2025–2028 · research · Alzheimer's Disease Research: Standard
Keeping Time: Illuminating and Resetting the Central Circadian Clock in Tauopathy
Jae-Eun Miller · Columbia University
2025–2027 · research · National Glaucoma Research: Standard
Role of CGRP in aqueous humor outflow homeostasis
Colleen Mcdowell · University of Wisconsin–Madison
2025–2027 · research · Macular Degeneration Research: Standard
The Role of Microglia in Modifying Disease Progression
Nobuhiko Shiraki · Duke University
2025–2027 · research · Alzheimer's Disease Research: Standard
Mechanisms of JADE1-mediated modulation of tau proteostasis
Marcos Schaan Profes · Icahn School of Medicine at Mount Sinai
2025–2028 · research · Macular Degeneration Research: Standard
Immune Aging in Vascular Remodeling and Subretinal Fibrosis in AMD
Masayuki Hata · Kyoto University
2025–2028 · research · Macular Degeneration Research: Standard
From Fumarates to Microtubules: novel anti-angiogenic and anti-fibrotic therapies for AMD
Daisy Shu · UNSW Sydney
2025–2027 · research · National Glaucoma Research: Standard
Building a 3D retinal organoid model for endogenous repair of human retinal ganglion cells.
Karl Wahlin · University of California San Diego